The tube lab market for me is primarily in biobanks. These groups have all been hard hit by COVID and unlikely to have much activity. While I should have seen this coming as I am in the industry and sell to said biobanks I didnt sell at 7 as i underestimated the normalisation time for these groups. I would say things are starting to improve in the US so we should see more opportunities over the next 12 months as things normalise. Dont hold your breath or the next 3-6 though.
The tube lab market for me is primarily in biobanks. These...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
